PlainPharmaWatch

CMS Open Payments · Program Year 2024

Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. reported $3,899,028.31 in payments to 315 physicians and teaching hospitals across 708 transactions.

See the rankings → How this is sourced
$3.9M
Total payments
708
Transactions
315
Recipients
+$405.4K
General Payments vs PY2023

Amicus Therapeutics, Inc. reported $3,899,028.31 in payments to 315 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #312 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $12.4K per recipient across 6 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Amicus Therapeutics, Inc. pairs top-quartile payment volume with a moderately concentrated payment pattern.

#312
of 1,925 companies
0.0%
of all US industry payments
0.4%
paid to its single top recipient
6
payment categories

Release-over-release change

General Payments changed from PY2023 to PY2024

Amicus Therapeutics, Inc.'s CMS-reported General Payments increased by $405.4K (+145.2%) from PY2023 to PY2024. The comparison uses the same CMS manufacturer-by-payment-category summary for both years and excludes research and ownership or investment records.

CMS source labels for this exact identifier: PY2022: AMICUS THERAPEUTICS, INC.PY2023: AMICUS THERAPEUTICS, INC.PY2024: Amicus Therapeutics, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$279.2KPY2024$684.6K
PY2023
$279,216.96
PY2024
$684,586.51

How Amicus Therapeutics, Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Amicus Therapeutics, Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$3,899,028 Top 16% higher than 84% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). Below this entry. $752,621–$2,337,813: 263 reporting companies (14%). Below this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). This entry sits in this band. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Amicus Therapeutics, Inc.

In Program Year 2024, Amicus Therapeutics, Inc. reported $3,899,028.31 in payments to 315 physicians and teaching hospitals across 708 individual transactions, an average of $5.5K per transaction and $12.4K per recipient. That total places Amicus Therapeutics, Inc. at rank #312 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

"Compensation for Services Other Than Consulting" leads the 6-category general-payment breakdown below at $310.3K (8.0% of the company's reported total, 34 transactions) - see our methodology for how research and ownership payments are reported separately.

General Payment Breakdown by Type

Amicus Therapeutics, Inc. made 6 types of general payments. "Compensation for Services Other Than Consulting" is the largest category at $310.3K, 8.0% of the company's reported total.

How Amicus Therapeutics, Inc. divides its payments

Ranked by total dollars reported per category

1. Compensation for Services…$310.3K2. Consulting Fee$196.5K3. Travel and Lodging$133.2K4. Space Rental or Facility …$22.0K5. Charitable Contribution$15.0K6. Food and Beverage$7.6K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $310.3K 34
Consulting Fee $196.5K 50
Travel and Lodging $133.2K 56
Space Rental or Facility Fees $22.0K 4
Charitable Contribution $15.0K 1
Food and Beverage $7.6K 170

Recipient Concentration in General Payments

The five largest recipient relationships account for $480,922.66 (70.3%) of $684,586.51 in this company's General Payments records across 147 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Amicus Therapeutics, Inc.

The five named recipients with the highest reported General Payments from this company

Hospital Of The Univ Of Penna$246.7KDuke University Hospital$78.6KMartin Bedigian$70.0KPriya Kishnani$43.6KTahseen Mozaffar$42.0K
  1. 1

    Hospital Of The Univ Of Penna

    $246,712.56 across 23 reported transactions

  2. 2

    Duke University Hospital

    $78,591.00 across 12 reported transactions

  3. 3

    Martin Bedigian

    $70,000.00 across 6 reported transactions

  4. 4

    Priya Kishnani

    $43,639.69 across 22 reported transactions

  5. 5

    Tahseen Mozaffar

    $41,979.41 across 20 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $5.5K. Average per recipient: $12.4K.

Total Amount

$3,899,028.31

Avg per Transaction

$5.5K

Avg per Recipient

$12.4K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Amicus Therapeutics, Inc. Share

0.0%

#312 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Amicus Therapeutics, Inc.

SmartHealth Inc

$3.9M 0 recipients

Blue Earth Diagnostics Limited

$3.9M 3,151 recipients

Harmony Biosciences LLC

$3.8M 22,211 recipients

Illumina, Inc.

$4.0M 105 recipients

Paragonix Technologies, Inc.

$4.0M 1,200 recipients

Impulse Dynamics (USA) Inc.

$4.0M 6,539 recipients

Frequently Asked Questions

How much did Amicus Therapeutics, Inc. pay to physicians and hospitals in 2024? ▾
In Program Year 2024, CMS Open Payments recorded $3,899,028.31 from Amicus Therapeutics, Inc. to physicians and hospitals across 708 transactions - 0.0% of all industry payments reported that year.
How many physicians received payments from Amicus Therapeutics, Inc.? ▾
315 physicians and teaching hospitals received payments from Amicus Therapeutics, Inc. in 2024, averaging $12.4K per recipient.
What types of payments did Amicus Therapeutics, Inc. make? ▾
General payments from Amicus Therapeutics, Inc. span 6 distinct categories, covering things like consulting, meals, and travel. The largest general-payment category was "Compensation for Services Other Than Consulting" at $310.3K, representing 8.0% of the company's reported total.
How does Amicus Therapeutics, Inc. rank among pharmaceutical companies? ▾
By total payment amount, Amicus Therapeutics, Inc. sits at #312 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Amicus Therapeutics, Inc.? ▾
Amicus Therapeutics, Inc.'s 708 transactions to 315 recipients in 2024 averaged $5.5K per transaction.
Where does the payment data for Amicus Therapeutics, Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Amicus Therapeutics, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.